Cargando…
Management of Metastatic Renal Cell Carcinoma in a Tertiary Care Hospital
Background The behavior of metastatic renal cell carcinoma (mRCC) is unpredictable and elusive. International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) scores, histological subtypes, and targeted therapy predict survival and prognosis. However, there is a paucity of literature from...
Autores principales: | Kumar, Sanjeev, Singh, Vishwajeet, Singh, Mukul K, Sankhwar, Satya N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063926/ https://www.ncbi.nlm.nih.gov/pubmed/37007390 http://dx.doi.org/10.7759/cureus.35623 |
Ejemplares similares
-
Sorafenib in the management of metastatic renal cell carcinoma
por: Guevremont, C., et al.
Publicado: (2009) -
Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
por: Schlemmer, Marcus, et al.
Publicado: (2019) -
Metastatic Renal Cell Carcinoma to the Scalp: A Case Report With Review of Literature
por: Meshikhes, Huda A, et al.
Publicado: (2023) -
Synchronous Metastatic Clear Cell Renal Cell Carcinoma to the Gallbladder With Metachronous Contralateral Recurrence
por: Pierce, Daniel P, et al.
Publicado: (2021) -
Exophytic Mass Around the Tip of the Nose: Unusual Presentation of Metastatic Renal Cell Carcinoma
por: Randhawa, GS, et al.
Publicado: (2022)